Hypertension in Long-Term Survivors of Pediatric Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 4, 2010, Pages 515-524

  Hoffmeister, Paul A ^a   Hingorani, Sangeeta R ^a,b   Storer, Barry E ^a   Baker, K Scott ^a,b   Sanders, Jean E ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Diabetes; Hematopoietic cell transplantation; Hypertension; Leukemia; Total body irradiation

Indexed keywords

CYCLOSPORIN A; GROWTH HORMONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HEALTH; CHRONIC GRAFT VERSUS HOST DISEASE; DIABETES MELLITUS; DONOR; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HORMONAL THERAPY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; WHOLE BODY RADIATION; INFANT; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVOR;

CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERTENSION; INCIDENCE; INFANT; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SURVIVORS;

EID: 77649339185     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.11.018     Document Type: Article

References (58)

1. Kumar M., Kedar A., and Neiberger R.E. Kidney function in long-term pediatric survivors of acute lymphoblastic leukemia following allogeneic bone marrow transplantation. Pediatr Hematol Oncol 13 (1996) 375-379
2. Leahey A.M., Teunissen H., Friedman D.L., Moshang T., Lange B.J., and Meadows A.T. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol 32 (1999) 163-169
3. Frisk P., Bratteby L.E., Carlson K., and Lonnerholm G. Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 29 (2002) 129-136
4. Kist-van Holthe J.E., Bresters D., Ahmed-Ousenkova Y.M., et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant 36 (2005) 605-610
5. Ong K.L., Cheung B.M., Man Y.B., Lau C.P., and Lam K.S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49 (2007) 69-75
6. Carretero O.A., and Oparil S. Essential hypertension. Part I: definition and etiology. Circulation 101 (2000) 329-335
7. Onusko E. Diagnosing secondary hypertension. Am Fam Phys 67 (2003) 67-74
8. Rizzo J.D., Wingard J.R., Tichelli A., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 12 (2006) 138-151
9. Zager R.A., O'Quigley J., Zager B.K., et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13 (1989) 210-216
10. Kist-van Holthe J.E., van Zwet J.M., Brand R., van Weel M.H., Vossen J.M., and van der Heijden A.J. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 22 (1998) 559-564
11. Hingorani S.R., Guthrie K., Batchelder A., et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 67 (2005) 272-277
12. Gruss E., Bernis C., Tomas J.F., et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 15 (1995) 473-479
13. Cohen E.P., and Robbins M.E. Radiation nephropathy. Semin Nephrol 23 (2003) 486-499
14. Taskinen M., Saarinen-Pihkala U.M., Hovi L., and Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356 (2000) 993-997
15. Lorini R., Cortona L., Scaramuzza A., et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 15 (1995) 873-877
16. Shalitin S., Phillip M., Stein J., Goshen Y., Carmi D., and Yaniv I. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 37 (2006) 1109-1117
17. Hoffmeister P.A., Storer B.E., and Sanders J.E. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol 26 (2004) 81-90
18. Baker K.S., Ness K.K., Steinberger J., et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109 (2007) 1765-1772
19. Thomas E.D., Storb R., Clift R.A., et al. Bone-marrow transplantation. N Engl J Med 292 (1975) 832-843 895-902
20. Sanders J.E., Storb R., Anasetti C., et al. Marrow transplant experience for children with severe aplastic anemia. Am J Ped Hematol Oncol 16 (1994) 43-49
21. Clift R.A., Buckner C.D., Thomas E.D., et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84 (1994) 2036-2043
22. Nemecek E.R., Gooley T.A., Woolfrey A.E., Carpenter P.A., Matthews D.C., and Sanders J.E. Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant 34 (2004) 799-806
23. Deeg H.J., Storer B., Slattery J.T., et al. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 100 (2002) 1201-1207
24. Thomas E.D., Sanders J.E., Flournoy N., et al. Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54 (1979) 468-476
25. Balduzzi A., Gooley T., Anasetti C., et al. Unrelated donor marrow transplantation in children. Blood 86 (1995) 3247-3256
26. Carella A.M., Champlin R., Slavin S., McSweeney P., and Storb R. Mini-allografts: ongoing trials in humans. Bone Marrow Transplant 25 (2000) 345-350
27. Hansen J.A., Mickelson E.M., Choo S.Y., et al. Clinical bone marrow transplantation: donor selection and recipient monitoring. In: Rose N.R., De Macario E.C., Fahey J.L., Friedman H., and Penn G.M. (Eds). Manual of Clinical Laboratory Immunology (1992), American Society for Microbiology, Washington, DC 850-866
28. Dupont B., and Yang S.Y. Histocompatibility. In: Forman S.J., Blume K.G., and Thomas E.D. (Eds). Bone Marrow Transplantation (1994), Blackwell Scientific Publications, Boston, MA 22-40
29. Storb R., Deeg H.J., Pepe M., et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: Long-term follow-up of a controlled trial. Br J Haematol 72 (1989) 567-572
30. Deeg H.J., Lin D., Leisenring W., et al. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. Blood 89 (1997) 3880-3887
31. Nash R.A., Antin J.H., Karanes C., et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96 (2000) 2062-2068
32. Martin P.J., Schoch G., Fisher L., et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 76 (1990) 1464-1472
33. Martin P.J., McDonald G.B., Sanders J.E., et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 10 (2004) 320-327
34. Martin P.J., Carpenter P.A., Sanders J.E., and Flowers M.E.D. Diagnosis and clinical management of chronic graft-versus-host disease. Int J Hematol 79 (2004) 221-228
35. Sala-Torra O., Martin P.J., Storer B., et al. Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and non-myeloablative conditioning regimens. Bone Marrow Transplant 41 (2008) 887-893
36. Shuhart M.C., Myerson D., Childs B.H., et al. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 84 (1994) 3229-3235
37. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 Suppl. 4th Report (2004) 555-576
38. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. [erratum appears in JAMA. 2003;290:197]. JAMA 289 (2003) 2560-2572
39. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-executive summary. National Institutes of Health, National Heart, Lung and Blood Institute. Available at; www nhlbi nih gov. 1998.
40. Kuczmarski R.J., Ogden C.L., Guo S.S., et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Sta Natl Center Health Stats. Series 11 (2002) 1-190
41. McDonald G.B., Hinds M.S., Fisher L.D., et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118 (1993) 255-267
42. Schwartz G.J., Brion L.P., and Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34 (1987) 571-590
43. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate [erratum appears in Ann Intern Med. 2008;149:519]. Ann Intern Med 145 (2006) 247-254
44. Andersen P.K., Borgan O., Gill R.D., and Keiding N. Statistical Models Based on Counting Processes (1993), Springer-Verlag, New York
45. Hennekens C.H., and Buring J.E. Measures of disease frequency and association. In: Mayrent S.L. (Ed). Epidemiology in Medicine (1987), Little, Brown and Company, Boston, MA 54-98
46. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 644;150:640-644.
47. Esiashvili N., Chiang K.Y., Hasselle M.D., Bryant C., Riffenburgh R.H., and Paulino A.C. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 90 (2009) 242-246
48. Weiss A.S., Sandmaier B.M., Storer B., Storb R., McSweeney P.A., and Parikh C.R. Chronic kidney disease following nonmyeloablative hematopoietic cell transplantation. Am J Transplant 6 (2006) 89-94
49. Hingorani S., Guthrie K.A., Schoch G., Weiss N.S., and McDonald G.B. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39 (2007) 223-229
50. Kersting S., and Verdonck L.F. Chronic kidney disease after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant 14 (2008) 403-408
51. Lawton C.A., Cohen E.P., Murray K.J., et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant 20 (1997) 1069-1074
52. Gronroos M.H., Bolme P., Winiarski J., and Berg U.B. Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 39 (2007) 717-723
53. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplant: epidemiology, pathogenesis and treatment. J Am Soc Nephrol 17 (2006) 1995-2005
54. Butt A.A., Xiaoqiang W., Budoff M., Leaf D., Kuller L.H., and Justice A.C. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 49 (2009) 225-232
55. Tarbell N.J., Guinan E.C., Chin L., Mauch P., and Weinstein H.J. Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol 18 Suppl. 1 (1990) 139-142
56. Gurney J.G., Ness K.K., Sibley S.D., et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107 (2006) 1303-1312
57. Franklin S.S., Jacobs M.J., Wong N.D., L'Italien G.J., and Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37 (2001) 869-874
58. Chow E.J., Pihoker C., Hunt K., Wilkinson K., and Friedman D.L. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer 110 (2007) 2313-2320